Lu Yao, Ye Zhang, Wong Gordon Tin Chun, Dong Chunshan, Yu Junma
Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China ; Department of Anesthesiology, Third Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Department of Anesthesiology, Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Indian J Pharmacol. 2013 Nov-Dec;45(6):619-21. doi: 10.4103/0253-7613.121376.
The aim of this study was to investigate the efficacy of dezocine (DEZ) versus placebo control (CON) and 2% lidocaine (LID) in prevention of injection pain due to DEZ.
A prospective randomized double-blind, placebo-CON study was conducted in 75 adults, American Society of Anesthesiologists physical status I or II, scheduled to undergo an elective surgery. A total of 25 patients were randomly assigned to one of the three groups, thus CON, group LID and group DEZ. The groups received either 2 ml of normal saline or 2 ml 2% LID or 2 mg/2 ml DEZ, respectively, as pre-treatment. Propofol was injected 1 min later. A blinded researcher assessed the patient's pain level using a four point verbal rating scale.
Less patients experienced pain due to propofol injection in the LID (40%) and DEZ (28%) groups compared with the CON (84%) group (P < 0.05). Six patients (24%) in the CON group reported severe pain during propofol injection but none in the other two groups.
Pre-treatment with DEZ decreases propofol injection pain as effectively as LID.
本研究旨在探讨地佐辛(DEZ)与安慰剂对照(CON)以及2%利多卡因(LID)预防因地佐辛引起的注射疼痛的疗效。
对75例计划接受择期手术、美国麻醉医师协会身体状况为I或II级的成年人进行了一项前瞻性随机双盲、安慰剂对照研究。总共25例患者被随机分配到三组之一,即CON组、LID组和DEZ组。三组分别接受2 ml生理盐水或2 ml 2%利多卡因或2 mg/2 ml地佐辛作为预处理。1分钟后注射丙泊酚。一名盲法研究人员使用四点语言评定量表评估患者的疼痛程度。
与CON组(84%)相比,LID组(40%)和DEZ组(28%)中因丙泊酚注射而经历疼痛的患者较少(P < 0.05)。CON组中有6例患者(24%)在丙泊酚注射期间报告有严重疼痛,而其他两组均无。
地佐辛预处理在减轻丙泊酚注射疼痛方面与利多卡因同样有效。